Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
---|
03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
03/27/2007 | CA2169145C Substituted benzisoxazole and benzisothiazole herbicidal agents |
03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | US20070066831 combining a 4-(halomethyl)benzonitrile with a metal salt of 1H-1,2,4triazole and a solvent selected from dimethylacetamide, N-methyl-2-pyrrolidone, thereby forming 4-[1-(1,2,4-triazolyl)methyl]benzonitrile; reacting formed intermediate with with 4-halobenzonitrile in presence of a base to form letrozole |
03/22/2007 | US20070066586 Aniline derivatives |
03/22/2007 | US20070066488 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/21/2007 | EP1764362A1 Biaryl derivatives |
03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
03/21/2007 | CN1934095A Ion channel modulators |
03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
03/21/2007 | CN1934074A Fungicidal phenoxyphenylhydrazine derivatives |
03/21/2007 | CN1933832A Ion channel modulators |
03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
03/20/2007 | US7192657 Ethynyl containing electron transport dyes and compositions |
03/20/2007 | CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production |
03/15/2007 | WO2007030680A2 Triazole derivatives useful as axl inhibitors |
03/15/2007 | CA2621503A1 Triazole derivatives useful as axl inhibitors |
03/14/2007 | EP1761543A1 Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same |
03/14/2007 | CN1930166A 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds |
03/14/2007 | CN1930165A 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
03/14/2007 | CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
03/14/2007 | CN1930143A MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
03/14/2007 | CN1927827A Process to prepare aryltriazolinones and novel intermediates thereto |
03/14/2007 | CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals |
03/08/2007 | US20070054907 Peroxisome Proliferator-Activated Receptor (PPAR) receptor modulators such as Ethyl(4-{4-[5-(4-tert-butylphenyl)-4-methyl-4H-[1,2,4]-triazol-3-ylsulfanyl]-2-heptyloxybenzylamino}phenyl)acetate, used in dermatology, cardiovascular diseases, immunology and/or diseases linked to lipid metabolism |
03/08/2007 | CA2618970A1 Lisofylline analogs and methods for use |
03/07/2007 | EP1758872A1 Process for the preparation of anastrozole |
03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
03/07/2007 | CN1926118A Dimeric small molecule potentiators of apoptosis |
03/07/2007 | CN1923819A compound containing aromatic ether and ditriazole and use thereof |
03/07/2007 | CN1303073C Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same |
03/06/2007 | US7186845 Polymer-filler coupling additives |
03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
03/06/2007 | CA1341521C 1-hydroxyethyl-azole derivatives, a process for their preparation and their use as plant growth regulators and fungicides |
03/01/2007 | WO2007023018A1 7-amino-6-triazolyl-1,2,4-triazolo[1,5-a]pyrimidine compounds and the use thereof for controlling harmful fungi |
03/01/2007 | WO2007022845A1 Novel materials for organic electroluminescent devices |
03/01/2007 | WO2007002722A3 Synthesis of anastrozole and purification of one of its intermediate |
03/01/2007 | WO2006034266A3 Sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
03/01/2007 | US20070049755 Novel triazolo pyrimidine compounds |
03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
03/01/2007 | US20070048673 Perfluoropolyether benzotriazole compounds |
02/28/2007 | EP1756113A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
02/28/2007 | CN1922156A Substituted triazoles as sodium channel blockers |
02/28/2007 | CN1919846A Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
02/27/2007 | US7183320 For therapy of neoplastic diseases |
02/22/2007 | WO2007019660A2 Azole compounds used as tuberculostatic and leishmanicide agents |
02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
02/22/2007 | US20070043512 Therapeutic and prophylactic compositions and uses therefor |
02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
02/21/2007 | EP1753732A1 Phenyl-sulfamates as aromatase inhibitors |
02/21/2007 | EP1753730A1 Dipeptidyl peptidase inhibitors |
02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
02/21/2007 | CN1918165A Azabicyclic heterocycles as cannabinoid receptor modulators |
02/21/2007 | CN1918164A Azabicyclic heterocycles as cannabinoid receptor modulators |
02/21/2007 | CN1918132A Method of coloring with capped diazotized compound and coupling component |
02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
02/20/2007 | US7179924 Use of benzotriazole UV absorbers |
02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
02/20/2007 | US7179804 Tachykinin receptor antagonists |
02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
02/20/2007 | CA2344574C Thyroid receptor ligands |
02/20/2007 | CA2174411C 2-(2-hydroxy-3-.alpha.-cumyl-5-alkylphenyl)-2h benzotriazoles |
02/15/2007 | WO2006103119A3 Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
02/14/2007 | EP1751121A2 Process for the preparation of anastrozole |
02/14/2007 | EP1751120A2 Substituted triazoles as modulators of ppar and methods of their preparation |
02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
02/14/2007 | CN1914183A Perfluoropolyether benzotriazole derivatives and use thereof as coatings |
02/13/2007 | US7176330 Fluorescent group-containing carbodiimide compound precursor, fluorescent group-containing carbodiimide compound and methods for producing them |
02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176237 Tricyclic-bis-enone derivatives and methods of use thereof |
02/13/2007 | US7176226 Exhibits excellent microbicidal action and can be employed for controlling unwanted microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials |
02/13/2007 | CA2387198C Method for treating hair loss using thyromimetic compounds |
02/08/2007 | WO2007015805A1 1-amino linked compounds |
02/08/2007 | US20070032660 Purification process for Anastrozole intermediate |
02/08/2007 | US20070032492 Cytokine Inhibitors |
02/07/2007 | EP1749823A1 Amine compound and organic electroluminescent element employing the same |
02/07/2007 | EP1748979A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
02/07/2007 | CN1910164A Organic compounds |
02/07/2007 | CN1910161A Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
02/07/2007 | CN1910147A Malononitrile compound and use thereof |
02/07/2007 | CN1909902A Triazole, oxadiazole and thiadiazole derivatives as PPAR modulators for the treatment of diabetes |
02/07/2007 | CN1298711C Processes for producing epoxytriazole derivative and intermediate therefor |
02/07/2007 | CN1298708C Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use |